Evidence map›Paper›PMID 40283713›Full record

ArticleInternational journal of environmental research and public health2025

Functional Limitations and Use of General Health Examination and Cancer Screening Among People with Disabilities Who Need Support from Others: Secondary Data Analysis of the 2022 Comprehensive Survey of Living Conditions in Japan.

Takashi Saito, Kumiko Imahashi, Chikako Yamaki

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Takashi SaitoDepartment of Social Rehabilitation, Research Institute of National Rehabilitation Center for Persons with Disabilities, 4-1 Namiki, Tokorozawa 359-8555, Japan.ORCID 0000-0002-7742-8457
Kumiko ImahashiDepartment of Social Rehabilitation, Research Institute of National Rehabilitation Center for Persons with Disabilities, 4-1 Namiki, Tokorozawa 359-8555, Japan.ORCID 0000-0001-7274-0022
Chikako YamakiInstitute for Cancer Control, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku 104-0045, Japan.

Funding

The Ministry of Health, Labor, and Welfare of Japan 23EA1030
6 · The paper itself

Abstract

Functional limitations that compromise preventive healthcare service utilization by people with disabilities in Japan are unelucidated. Secondary data from the Comprehensive Survey of Living Conditions (CSLC) in 2022 on the functional limitations defined by the Washington Group Short Set may bridge the knowledge gap, with evaluation of the generalizability of the knowledge as CSLC2022 was conducted in the aftermath of the COVID-19 pandemic. We described the number and types of functional limitations among people with disabilities who did not participate in the general health examination and cancer screenings. For the generalizability evaluation, we analyzed preventive service uptake and its relevance to disability status and compared them with compatible data from the CSLC from 2016, conducted before the pandemic. Among the eligible data, the percentage of people with disabilities among the preventive healthcare service non-participants was 2.40-3.66% (

Indexed as

Early Detection of CancerNeoplasmsPersons with DisabilitiesActivities of Daily LivingAdultAgedCOVID-19FemaleHumansJapanMaleMiddle AgedSecondary Data Analysiscancer screeningdisabilitydisparityfunctional limitationgeneral health examinationJapanWashington Group on Disability Statistics

Identifiers

PMID40283713
PMCPMC12026762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.